$19.99
Stay ahead of regulatory changes in healthcare compliance with this targeted course on the Federal Anti-Kickback Statute and Beneficiary Inducements Civil Monetary Penalty (CMP) provisions for direct-to-consumer (DTC) prescription drug programs. Explore the latest Request for Information (RFI) from HHS and the OIG, the impact of platforms like TrumpRx, and discover how evolving rules could affect pharmaceutical manufacturers, healthcare providers, and patient access. Learn how your feedback and participation may shape the future of DTC drug sales, safe harbor regulations, and fraud prevention in federal health programs.
In this course you will learn the following:
* Understand the goals and intent of the RFI and the underlying regulatory framework.
* Recognize the significance of public feedback in shaping future regulations.
* Identify the key areas under review, including safe harbors and exceptions related to DTC prescription drug programs.
* Appreciate that the rulemaking process is ongoing and subject to change based on comments received.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Without this course, you may overlook critical compliance requirements and miss the opportunity to influence or prepare for regulatory shifts that could impact how prescription drugs are sold directly to consumers under federal programs.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP.
Key regulatory references include:
Course SKU
FR-26-1698-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Federal Acquisition Regulation: Prohibition on Certain Semiconductor Products and Services. Document Number: 2026-03065
Buy this Course
FR-26-1735-1
Why This Course is Important
Failure to take this course could leave you unprepared for significant contract compliance changes, risking loss of contract eligibility and exposure to penalties for non-compliance with upcoming federal semiconductor procurement prohibitions.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Federal Acquisition Regulation: Prohibition on Certain Semiconductor Products and Services.
Key regulatory references include:
Course SKU
FR-26-1735-1
© 2026 CourseAvenue, LLC | All rights reserved.
